Financials
- Market Capitalization 3.87 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-19.51
Rapporto prezzo/fatturato
14.28
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1518 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -15.19% | +253.10% | 3.94 B USD | ||
| 1532 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +68.72% | +277.61% | 3.87 B USD | ||
| 1541 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | -1.40% | +48.42% | 3.84 B USD | ||
| 1544 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.29 USD | -0.79% | -1.48% | +12.90% | +78.92% | 3.82 B USD |